Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VIS649 (Sibeprenlimab), an APRIL-Neutralizing IgG

Name: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VIS649 (Sibeprenlimab), an APRIL-Neutralizing IgG
Author: Mathur, Mohit

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VIS649 (Sibeprenlimab), an APRIL-Neutralizing IgG — المؤلف: Mathur, Mohit — Kidney international reports May 2022

المؤلف: Mathur, Mohit
النشر: Kidney international reports May 2022
الوصف: 993-1003 p.